CHOP and Penn researchers have developed a proof-of-concept model for delivering gene editing tools to treat blood disorders directly within the body.

Children’s Hospital of Philadelphia (CHOP) announced it has received $1 million from Pediatric Cancer Foundation, an organization that has been raising funds for research since 1970 to support doctors and hospitals in an effort to eradicate childhood cancer. The grant will help to fund a planned first-in-human phase 1 clinical trial led by Sarah K. Tasian, MD, which will use a new immunotherapy to target the FLT3 receptor protein in high-risk pediatric leukemias.

U.S. News & World Report recognized CHOP’s Orthopedics Center as the best in the nation for 2023-24.

For decades, doctors and researchers have been working diligently to discover new treatments and provide more options for patients with Duchenne muscular dystrophy (DMD), a debilitating genetic disease that ravages the muscles in the body and leads to a loss of movement and coordination.

Pediatricians (and parents) share the must-haves they keep in their kids’ travel kits, including the 3 Ps of packing.

While those who were thought to put children at risk were viewed negatively, a large number of caregivers supported education efforts and technology use to reduce heatstroke risk.

This year’s conference brought participants and presenters from around the globe to share insights and knowledge about diagnosing and treating lymphatics conditions.

Cervical cancer patients share their thoughts about trigger words in a recent Cervivor’s blog post, and the National Foundation for Infectious Diseases offers “Infectious IDeas” podcast. Check them out!

The updated edition of “Trust Me, I am Lying” by Ryan Holiday describes why “the facts” often can’t compete with the media narrative.

Children’s Hospital of Philadelphia (CHOP) has announced that the organization is now a part of KidsX, a global leader in pediatric digital health innovation. KidsX facilitates collaboration between elite children’s hospitals, providers, payors, investors, entrepreneurs, and corporate partners to solve the most pressing problems in pediatric care delivery.